Skip to main content

Table 2 Medications used by participants during study period—comparison between the two study groups (2866 participants)

From: HbA1C variability among type 2 diabetic patients: a retrospective cohort study

Variable HbA1C variability (N = 632) No HbA1C variability (N = 2234) p value
Insulin: (N = 1217) 71.2% (450) 34.3% (767) < 0.001
Diabetes oral treatment: (N = 2847) 100% (632) 99.1% (2215) 0.012
Statins: (N = 2689) 94.6% (598) 93.6% (2091) 0.346
ARB’s and ACE inhibitors: (N = 2556) 93.5% (591) 88% (1965) < 0.001